No Evidence That Therapeutic Systemic Corticosteroid Administration is Associated With Laminitis in Adult Horses Without Underlying Endocrine or Severe Systemic Disease.

Clinical bottom line There is currently no conclusive evidence to support a causal association between therapeutic systemic corticosteroid administration and the development of laminitis in healthy adult horses/ponies. There is weak evidence of an association between administration of multiple doses of systemic corticosteroid and the onset of laminitis in adult horses/ponies with underlying endocrine disorders or severe systemic disease.

[1]  T. Olivry,et al.  Pemphigus vulgaris in a Welsh pony stallion: case report and demonstration of antidesmoglein autoantibodies. , 2013, Veterinary dermatology.

[2]  M. McCluskey,et al.  Clinical use of triamcinolone acetonide in the horse (205 cases) and the incidence of glucocorticoid‐induced laminitis associated with its use , 2010 .

[3]  C. McGowan.  The Role of Insulin in Endocrinopathic Laminitis , 2008 .

[4]  L. J. McCutcheon,et al.  Effects of dexamethasone administration on insulin resistance and components of insulin signaling and glucose metabolism in equine skeletal muscle. , 2008, American journal of veterinary research.

[5]  R. Boston,et al.  Effect of dietary fructans and dexamethasone administration on the insulin response of ponies predisposed to laminitis. , 2007, Journal of the American Veterinary Medical Association.

[6]  L. J. McCutcheon,et al.  Effects of dexamethasone on glucose dynamics and insulin sensitivity in healthy horses. , 2007, American journal of veterinary research.

[7]  N. E. Robinson,et al.  Thermographic study of in vivo modulation of vascular responses to phenylephrine and endothelin-1 by dexamethasone in the horse. , 2010, Equine veterinary journal.

[8]  P. Eyre,et al.  Corticosteroid-induced laminitis? Further observations on the isolated, perfused hoof , 1980, Veterinary Research Communications.

[9]  P. Kass,et al.  Pemphigus foliaceus in the horse: a retrospective study of 20 cases. , 2004, Veterinary dermatology.

[10]  Yonghoon Lee,et al.  Glucocorticoid-induced laminitis with hepatopathy in a Thoroughbred filly. , 2004, Journal of veterinary science.

[11]  V. Ganjam,et al.  Endocrinopathic laminitis in the horse , 2004 .

[12]  V. Ganjam,et al.  Glucocorticoids and laminitis in the horse. , 2002, The Veterinary clinics of North America. Equine practice.

[13]  C. Pollitt,et al.  Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses. , 2000, Journal of veterinary pharmacology and therapeutics.

[14]  P. Cripps,et al.  Factors involved in the prognosis of equine laminitis in the UK. , 1999, Equine veterinary journal.

[15]  D. Hood,et al.  Descriptive epidemiological study of equine laminitis. , 1995, Equine veterinary journal.

[16]  T. Tobin,et al.  Clinical use and characteristics of the corticosteroids. , 1993, The Veterinary clinics of North America. Equine practice.

[17]  N. Cohen,et al.  Steroid hepatopathy in a horse with glucocorticoid-induced hyperadrenocorticism. , 1992, Journal of the American Veterinary Medical Association.

[18]  J. Beech,et al.  Azathioprine for treatment of immune-mediated thrombocytopenia in two horses. , 1991, Journal of the American Veterinary Medical Association.

[19]  Lose Mp.  Drug-induced laminitis in a colt. , 1980 .

[20]  M. Lose.  Drug-induced laminitis in a colt. , 1980, Modern veterinary practice.

[21]  E. Muylle,et al.  Lung function tests in obstructive pulmonary disease in horses. , 1973, Equine veterinary journal.